MGX (Metagenomi) Total Equity : $234.86 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Total Equity?

Metagenomi's total equity for the quarter that ended in Dec. 2024 was $234.86 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Metagenomi Total Equity Historical Data

The historical data trend for Metagenomi's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi Total Equity Chart

Metagenomi Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Equity

-32.54

-74.43

-135.58

234.86

Metagenomi Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Equity	Get a 7-Day Free Trial							-135.58	275.63	269.42	255.77	234.86

Metagenomi Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Metagenomi's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	324.599	-	89.742
	=	234.86

Metagenomi's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	324.599	-	89.742
	=	234.86

Metagenomi Total Equity Related Terms

Thank you for viewing the detailed overview of Metagenomi's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Metagenomi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, Emeryville, CA, USA, 94608

Website

https://www.metagenomi.co

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).